Medicare Readmissions Reduction Program: Outcomes, Costs, and Inadvertent Effects

医疗保险再入院减少计划：结果、成本和意外影响

• 批准号: 9135273
• 负责人: Teryl Nuckols
• 金额: $ 39.8万
• 依托单位: CEDARS-SINAI MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-30 至 2018-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9135273
• 关键词: Medicare; Readmissions; Reduction; Program; Outcomes

 DESCRIPTION (provided by applicant): Readmissions occur commonly among the elderly, are associated with suboptimal care and worse clinical outcomes, and contribute substantially to healthcare costs. In September 2012, the Centers for Medicare and Medicaid Services implemented the Hospital Readmissions Reduction Program. The policy financially penalizes hospitals with higher-than-expected 30-day risk-adjusted readmission rates for adults age 65 and older with heart failure, myocardial infarction, and pneumonia, and, as of 2015, chronic obstructive pulmonary disease and arthroplasty of the hip and knee. Coronary artery bypass grafting will be added in 2017. Readmission rates have declined since 2012 but favorable effects on long-term outcomes and costs are not assured. Survival could improve if hospitals improve inpatient and transition-related care, although length of stay and use of formal post-acute care could rise as hospitals strive to ensure clinical stability after discharge. Conversely, hospitals could engage in gaming, such as readmitting only the sickest patients, substituting observation stays for readmissions, or postponing readmissions beyond 30 days. Barriers to necessary readmission could lead to greater utilization of emergency department visits and worse survival. As hospitals create new systems of care, both favorable and unfavorable effects could affect patients not targeted by the policy. This project seeks to evaluate the Program's effects on survival, healthcare utilization, and payments by Medicare, and to consider potential inadvertent effects. First, the project will evaluate how the policy has influenced beneficiaries' survival during the six months after hospitalization, an outcome important to patients. Second, the project will evaluate 30-day readmission rates, utilization of hospital and post-acute care, and payments by Medicare. Finally, the analysis will examine gaming by hospitals and spillover effects for populations not targeted by the policy. Methods will involve using Medicare administrative data to measure changes in clinical and economic outcomes from before to after policy implementation, using an interrupted time-series design. To present results in formats that are easy for policymakers and stakeholders to understand, the analysis will use estimates from the models in simulations that predict outcomes with and without the HRRP. Lastly, because hospitals may respond differently based on the percent of revenue at risk, we will examine whether effects differ across hospitals according to each hospital's share of patients with Medicare insurance or each hospital's penalty size.

 描述（由申请人提供）：老年人中经常发生再入院，与次优护理和更差的临床结局相关，并对医疗费用有很大贡献。2012年9月，医疗保险和医疗补助服务中心实施了医院再入院减少计划。该政策在经济上惩罚了65岁及以上患有心力衰竭，心肌梗死和肺炎的成年人的30天风险调整再入院率高于预期的医院，以及截至2015年的慢性阻塞性肺病和髋关节和膝关节置换术。2017年将增加冠状动脉旁路移植术。 自2012年以来，再入院率有所下降，但对长期结果和成本的有利影响并不确定。如果医院改善住院和过渡相关的护理，生存率可能会提高，尽管住院时间和使用正式的急性后护理可能会增加，因为医院努力确保出院后的临床稳定性。相反地， 医院可以玩游戏，比如只让病情最严重的病人重新入院，以观察住院代替重新入院，或者将重新入院推迟30天以上。必要再入院的障碍可能会导致更多的急诊就诊和更差的生存率。随着医院创建新的护理系统，有利和不利的影响都可能影响到政策没有针对的患者。 该项目旨在评估该计划对生存，医疗保健利用和医疗保险支付的影响，并考虑潜在的无意影响。首先，该项目将评估该政策如何影响受益人在住院后六个月内的生存，这是一个对患者很重要的结果。其次，该项目将评估30天再入院率、医院和急性期后护理的利用率以及医疗保险的支付情况。最后，分析将研究医院的博弈和政策未针对人群的溢出效应。 方法将涉及使用医疗保险管理数据来衡量从政策实施之前到之后的临床和经济结果的变化，使用中断的时间序列设计。为了以政策制定者和利益相关者易于理解的格式呈现结果，分析将使用模拟模型中的估计值，预测有和没有HRRP的结果。最后，由于医院可能会根据风险收入的百分比做出不同的反应，我们将根据每家医院的医疗保险患者比例或每家医院的罚款规模来检查医院之间的影响是否不同。